Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Endometrial Neoplasms × apatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 6 Stomach Neoplasms 3 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Thymic epithelial tumor 1 Solid Tumor 1 Sarcoma 1 Ovarian Cancer Recurrent 1 Neuroendocrine Tumors 1 Locally Advanced Gastric Cancer 1 Liver Neoplasms 1 Liposarcoma 1 HR+/HER2-breast Cancer 1 Gastric Adenocarcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Gastric Cancer 1

Interventions

Paclitaxel 8 Carboplatin 6 Tirzepatide 3 Observation 3 Cisplatin 3 dostarlimab 2 Progestins 2 Megestrol Acetate 2 Medroxyprogesterone Acetate 2 Bevacizumab 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sintilimab 1 semaglutide 1 pembrolizumab 1 olaparib 1 montelukast 1 enfortumab vedotin 1 bemarituzumab 1 apatinib 1 Watchful Waiting 1 Vaginal Smears 1 Topotecan 1 Tablets 1 Specimen Handling 1 Sensitivity Training Groups 1 Resistance Training 1 Platinum 1 Palliative Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06771154 2025-01-13

A-CAPE

Peking Union Medical College Hospital

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡